Despite Switzerland being known as one of the most innovative nations, latest reports have shown a 10% decline in the country’s research and development spending. This comes as a surprise due to the fact that worldwide R&D expenditure has reached an all-time high of $782 billion. The biggest Swiss companies invested $27.5 billion into R&D in 2018. The majority of the decline has come from Basel-based giant pharmaceutical companies Roche and Novartis. Roche spent around $1 billion less on R&D […]
In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]
The functional cosmetics brand, Cellmid Limited has received an $808,000 research and development grant under the tax incentive scheme from the Australian Taxation Office. Cellmid is an Australian life sciences accelerator with lead programs in multiple disease indications. The company holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5, which are growth promoting protein supplements and products. After Cellmid generated $5.64 million in revenue for FY18 and continues to rapidly […]
Last week, the Government introduced changes to the R&D Tax Incentive as part of an Omnibus Bill, following an announcement of the changes in May’s Federal Budget. It is uncertain whether the Bill will pass both the lower house of parliament and the Senate. The revisions are proposed to apply for the 2019 Financial Year. View the first reading of the bill here.